A severe clinical phenotype results from the co-inheritance of type 2 susceptibility genes and a hepatocyte nuclear factor-1α mutation [9]

Diabetes Care

Volumn 23, Issue 3, 2000, Pages 424-425

  Tack, Cees J J ^a   Ellard, Sian ^b   Hattersley, Andrew T ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; NUCLEAR FACTOR I; SULFONYLUREA DERIVATIVE;

AUTOSOMAL DOMINANT INHERITANCE; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GENE DOSAGE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONSENSE MUTATION; OBESITY; ONSET AGE; PHENOTYPE;

EID: 0034007210     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.3.424     Document Type: Letter

References (9)

1. Hattersley AT: Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 15:15-24, 1998
2. Frayling TM, Bulman MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT: Mutations in the hepatocyte nuclear factor - 1α gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46:720-725, 1997
3. Moller AM, Dalgaard I.T, Pociot F, Nerup J, Hansen T, Pedersen O: Mutations in the hepatocyte nuclear factor - 1α gene in Caucasian families originally classified as having type 1 diabetes. Diabetologia 41:1528-1531, 1998
4. Yamada S, Nishigori H, Onda H, Utsugi T, Yanagawa T, Maruyama T, Onigata K, Nagashima K, Nagai R, Morikawa A, Takeuchi T, Takeda J: Identification of mutations in the hepatocyte nuclear lacior (HNF)-1α gene in Japanese subjects with IDDM. Diabetes 46:1643-1647, 1997
5. Glucksmann MA, Lehto M, Tayber O, Scotti S, Berkemeier L, Pulido C, Wu Y, Nir W-J, Fang L, Markel P, Munnelly KD, Goranson J, Orho M, Young BM, Whitacre JL, McMenimen C, Wantman M, Tuomi T, Warram J, Krolewski AS, Groop LC, Thomas JD: Novel imitations and a mutational hotspot in the MODY3 gene. Diabetes 46:1081-1086, 1997
6. Hathout EH, Cockburn BN, Mace JW, Sharkey J, Chen-Daniel J, Bell GI: A case of hepatocyte nuclear factor-1α diabetes/ MODY3 masquerading as type 1 diabeics in a Mexican-American adolescent and responsive to a low dose of sulfonylurea. Diabetes Care 22:867-868, 1999
7. O'Rahilly S, Spivey RS, Holman RR, Nugent Z, Clark A, Turner RC: Type II diabetes of early onset: a distinct clinical and genetic syndrome? BMJ 294:923-928, 1987
8. Ellard S, Bulman MP, Frayling TM, Allen LIS, Dronsfield MJ, Tack CJ, Hattersley AT: Allelic drop-out in exon 2 of the hepatocyte nuclear factor-1α gene hinders the identification of mutations in three families with maturity-onset diabetes of the young. Diabetes 48:921-923, 1999
9. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen M-R, Groop L: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997